Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1
Authors:
- Vladimir FrecerVFVladimir Frecer
- Stanislav MiertusSMStanislav Miertus
- 1 April 2009
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 82 (1) , 51-58
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Design of peptidomimetic inhibitors of aspartic protease of HIV-1 containing –PheΨPro– core and displaying favourable ADME-related propertiesJournal of Molecular Graphics and Modelling, 2008
- Anti-influenza virus activity of peramivir in mice with single intramuscular injectionAntiviral Research, 2006
- Combinatorial design of nonsymmetrical cyclic urea inhibitors of aspartic protease of HIV-1Bioorganic & Medicinal Chemistry, 2005
- Structure-based design of inhibitors of NS3 serine protease of hepatitis C virusJournal of Molecular Graphics and Modelling, 2004
- Research and Development of a Second-Generation Process for Oseltamivir Phosphate, Prodrug for a Neuraminidase InhibitorOrganic Process Research & Development, 2003
- Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with OseltamivirThe Journal of Infectious Diseases, 2001
- Influenza virus neuraminidase inhibitorsThe Lancet, 2000
- Industrial Synthesis of the Key Precursor in the Synthesis of the Anti-Influenza Drug Oseltamivir Phosphate (Ro 64-0796/002, GS-4104-02): Ethyl (3R,4S,5S)-4,5-epoxy-3-(1-ethyl-propoxy)-cyclohex-1-ene-1-carboxylateOrganic Process Research & Development, 1999
- Prediction of binding constants of protein ligands: A fast method for the prioritization of hits obtained from de novo design or 3D database search programsJournal of Computer-Aided Molecular Design, 1998
- The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structureJournal of Computer-Aided Molecular Design, 1994